Abstract
The acute administration of 4-chloroamphetamine caused a marked reduction in the concentration of serotonin and 5-hydroxyindoleacetic acid and a rise in dopamine in the rat brain. Following the injection of 3H-tyrosine and 3H-tryptophane into rats treated with 4-chloroamphetamine, there was a reduction in brain levels of 3H-dopamine and 3H-serotonin. Although the endogenous concentration of noradrenaline was not affected by 4-chloroamphetamine, there is evidence that its reuptake into neurones was reduced and its release increased by the drug. Following the administration of 4-chloroamphetamine for 10 days, the concentration of 5-hydroxyindoleacetic acid was reduced; no other changes in amine metabolism were apparent. From this investigation, and those of others, it appears that following acute administration, 4-chloroamphetamine has a neurochemical profile which has a similarity to that of many tricyclic antidepressants. However, there is a marked discrepancy between the acute and chronic effects of 4-CA on brain amine metabolism. Such findings are difficult to reconcile with the widely accepted theory that antidepressant drugs counteract the symptoms of depression by increasing the concentration of noradrenaline and/or serotonin at receptor sites within the brain.
Similar content being viewed by others
References
Anden, N.-E., Atack, C. V., Srensson, T. H.: Release of dopamine from central noradrenergic and dopaminergic nerves induced by a dopamine Β-hydroxylase inhibitor. J. Pharmacol. exp. Ther. 138, 360–375 (1962)
Anton, A. H., Sayre, D. F.: The distribution of dopamine and dopa in various animals and a method for their determination in diverse biological material. J. Pharmacol. exp. Ther. 145, 326–336 (1964)
Anton, A. H., Sayre, D. F.: Distribution of metanephrine and normetanephrine in various animals and their analysis in diverse biological material. J. Pharmacol. exp. Ther. 153, 15–19 (1966)
Bunney, W. E., Davis, J. M.: Norepinephrine in depressive reactions. Arch. gen. Psychiat. 13, 483–494 (1965)
Carlsson, A., Fuxe, K., Hamberger, B., Malmfors, T.: Effect of a new series of bicyclic compounds with potential thymoleptic properties on the reserpine resistant uptake mechanisms of central and peripheral monoamine neurones in vivo and in vitro. Brit. J. Pharmacol. 36, 18–28 (1969)
Carlsson, A., Lindquist, M., Dahlstrom, A., Fuxe, K., Masuoka, D.: Effects of the amphetamine group on intraneuronal brain amines in vivo and in vitro. J. Pharm. Pharmacol. 17, 521–524 (1965)
Coppen, A.: Indoleamines and affective disorders. J. psychiat. Res. 9, 163–172 (1972)
Coppen, A., Shaw, D. M., Farrell, J. P.: Potentiation of the antidepressive effect of a monoamine oxidase inhibitor by tryptophan. Lancet 1963I, 79–81
Costa, E., Naimzada, K. M., Revuelta, A.: Effect of phenmetrazine, aminorex and (±)-p-chloroamphetamine on the motoractivity and turnover rate of brain catecholamines. Brit. J. Pharmacol. 43, 570–579 (1971)
Costa, E., Revuelta, A.: (−)p-Chloroamphetamine and serotonin turnover in rat brain. Neuropharmacology 11, 291–295 (1972)
Curzon, G., Green, A. R.: Rapid method for the determination of 5-hydroxytryptophan and 5-hydroxyindoleacetic acid in small regions of the rat brain. Brit. J. Pharmacol. 39, 653–655 (1970)
Fuller, R. W.: Serotonin oxidation by rat brain monoamine oxidase: inhibition by 4-chloroamphetamine. Life Sci. 5, 2247–2257 (1966)
Fuller, R. W., Hines, C. W., Mills, J.: Lowering of brain serotonin level by chloramphetamines. Biochem. Pharmacol. 14, 483–488 (1965)
Fuller, R. W., Schaffer, R. J., Roush, B. W., Molloy, B. B.: Drug disposition as a factor in the lowering of brain serotonin by chloramphetamines in the rat. Biochem. Pharmacol. 21, 1413–1417 (1972)
Giacolone, E., Valzelli, L.: A method for the determination of 5-hydroxyindolyl-3-acetic acid in brain. J. Neurochem. 13, 1265–1266 (1966)
Guroff, G., King, W., Udenfriend, S.: The uptake of tyrosine by rat brain in vitro. J. biol. Chem. 236, 1733–1777 (1961)
Hess, S., Udenfriend, S.: A fluorimetric procedure for the measurement of tryptamine in tissues. J. Pharmacol. exp. Ther. 127, 175–177 (1959)
Lapin, T. P., Oxenkrug, G. F.: Intensification of the ventral serotonergic processes as a possible determinant of the thymoleptic effect. Lancet 1969I, 132–136
Lassen, J. B.: The effect of p-chloroamphetamine on motility in rats after inhibition of monoamine synthesis, storage, uptake and receptor inactivation. Psychopharmacologia (Berl.) 34, 243–254 (1974)
Leonard, B. E.: Effect of four amphetamines on brain biogenic amines and their metabolites. Biochem. Pharmacol. 21, 1289–1297 (1972)
Leonard, B. E., Shallice, S. A.: Some neurochemical effects of amphetamine: methylamphetamine and p-bromomethylamphetamine in the rat. Brit. J. Pharmacol. 41, 198–212 (1971)
Leonard, B. E., Shallice, S. A.: The effect of some tryptamine derivatives on brain monoamines and their precursor amino acids. Neuropharmacology 11, 373–384 (1972)
Leonard, B. E., Tonge, S. R.: The effects of some hallucinogenic drugs upon the metabolism of noradrenaline. Life Sci. 8, 815–825 (1969)
Miller, F. P., Cox, R. H., Snodgrass, W. R., Maickel, R. P.: Comparative effects of p-chlorophenylalanine, p-chloroamphetamine and p-chloro-N-methylamphetamine on rat brain norepinephrine, serotonin and 5-hydroxyindole-3-acetic acid. Biochem. Pharmacol. 19, 435–442 (1970)
Moore, K. E., Lariviere, E. W.: Effects of d-amphetamine and restraint on the content of norepinephrine and dopamine in the rat brain. Biochem. Pharmacol. 12, 1283–1288 (1963)
Neff, N. H., Spano, P. F., Groppetti, A., Wang, C. T., Costa, E.: A simple procedure for calculating the synthesis rate of norepinephrine dopamine and serotonin in rat brain. J. Pharmacol. exp. Ther. 176, 701–710 (1971)
Pletscher, A., Bartholini, G., Bruderer, H., Burkard, W. P., Gey, K. F.: Chlorinated arylalkylamines affecting the cerebral metabolism of 5-hydroxytryptamine. J. Pharmacol. exp. Ther. 145, 344–350 (1964)
Pletscher, A., Da Prada, M., Burkard, W. P., Bartholini, G., Steiner, F. A., Bruderer, H., Bigler, F.: Aralkylamines with different effects on the metabolism of aromatic monoamines. J. Pharmacol. exp. Ther. 154, 64–72 (1966)
Van Praag, H. M., Kits, T. P., Schut, J., Dijkstra, P.: An attempt at indirect evaluation of the noradrenaline hypothesis. Results of a pilot study of the antidepressive qualities of a p-chloro-N-methylamphetamine. Psychiat. Neurol. Neurochir. 72, 181–187 (1969)
Van Praag, H. M., Korf, J.: 4-Chloramphetamines. Chance and trend in the development of new antidepressants. J. clin. Pharmacol. 13, 3–14 (1973)
Van Praag, H. M., Korf, J., van Woudenberg, F.: Investigation into the possible influence of chlorinated amphetamine derivatives on 5-hydroxytryptamine synthesis in man. Psychopharmacologia (Berl.) 18, 412–420 (1970)
Van Praag, H. M., Korf, J., van Woudenberg, F., Kits, T. P.: Influencing the human indoleamine metabolism by means of a chlorinated amphetamine derivative with anti-depressant action (p-chloro-N-methylamphetamine). Psychopharmacologia (Berl.) 13, 145–160 (1968)
Sanders-Bush, E., Bushing, J. A., Sulser, F.: Long term effects of p-chloroamphetamine of tryptophan hydroxylase activity and on the levels of 5-hydroxytryptamine and 5-hydroxytryptamine acid in brain. Europ. J. Pharmacol. 20, 385–388 (1972)
Scheel-Krüger, J.: Behavioural and biochemical comparison of amphetamine derivatives, cocaine benztropine and tricyclic anti-depressant drugs. Europ. J. Pharmacol. 18, 63–73 (1972)
Schildkraut, J. J.: The catecholamine hypothesis of affective disorders: a review of supporting evidence. Amer. J. Psychiat. 122, 509–533 (1965)
Schildkraut, J. J., Draskoczy, P. R., Gershon, E. S., Reich, P., Grab, E. L.: Catecholamine metabolism in affective disorders. IV. Preliminary studies of norephinephrine metabolism in depressed patients treated with amitriptyline. J. psychiat. Res. 9, 173–186 (1972)
Strada, S. J., Sanders-Bush, E., Sulser, F.: p-Chloroamphetamine: in vivo investigations on the mechanism of action of the selective depletion of cerebral serotonin. J. Pharmacol. exp. Ther. 175, 419–426 (1970)
Tagliamonte, A., Tagliamonte, P., Perez-Cruet, J., Stern, S., Gessa, G. L.: Increase of brain tryptophan caused by drugs which stimulate serotonin synthesis. Nature 229, 125–126 (1971)
Wong, D. T., van Frank, R. M., Horng, J.-S., Fuller, R. W.: Accumulation of amphetamine and p-chloroamphetamine into synaptosomes of rat brain. J. Pharm. Pharmacol. 24, 171–173 (1972)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Leonard, B.E. Acute and chronic effects of 4-chloroamphetamine on monoamine metabolism in the rat brain. Psychopharmacologia 46, 11–18 (1976). https://doi.org/10.1007/BF00421543
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00421543